Adherence to tamoxifen in breast cancer patients: What role does the pharmacist play in German primary care?

Abstract

Get full access to this article

View all access options for this article.

References

Ferlay

Soerjomataram

Dikshit

et al . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.

Kreienberg

Albert

Follmann

et al . Interdisciplinary GoR level III guidelines for the diagnosis, therapy and follow-up care of breast cancer. Senologie 2013;10:164-92.

Madlensky

Natarajan

Tchu

et al . Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes. Clin Pharmacol Ther 2011;89:718-25.

Klopp-Schulze

Joerger

Wicha

et al . Exploiting pharmacokinetic models of tamoxifen and endoxifen to identify factors causing subtherapeutic concentrations in breast cancer patients. Clin Pharmacokinet 2018;57:229-42.

Cardoso

Csajka

Schneider

Widmer

Effect of adherence on pharmacokinetic/pharmacodynamic relationships of oral targeted anticancer drugs. Clin Pharmacokinet 2018;57:1-6.

Sabaté

Adherence to long-term therapies: evidence for action. Geneva (Switzerland): World Health Organization; 2003.

Martin

Williams

Haskard

DiMatteo

MR.

The challenge of patient adherence. Ther Clin Risk Manag 2005;1:189-99.

Huiart

Ferdynus

Giorgi

A meta-regression analysis of the available data on adherence to adjuvant hormonal therapy in breast cancer: a summarizing the data for clinicians. Breast Cancer Res Treat 2013;138:325-8.

Fagerlin

Lakhani

Lantz

et al . An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns 2006;64:303-12.

10.

Sawesi

Carpenter

Jones

Reasons for nonadherence to tamoxifen and aromatase inhibitors for the treatment of breast cancer: a literature review. Clin J Oncol Nurs 2014;18:E50-7.

11.

Liu

Malin

J L

Diamant

et al . Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication. Breast Cancer Res Treat 2013;137(3):829-36.

12.

Dunbar-Jacob

Adherence in chronic disease. Ann Rev Nurs Res 2000;18:48-90.

13.

Holman

HR.

Evidence that an education program for self-management of chronic disease can improve health status while reducing healthcare costs: a randomized trial (abstract). Assoc Health Serv Res 1997;14:19-20.

14.

Hansen

Kim

Song

et al . Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 2009;43:413-22.

15.

Van’t Veer

Dai

van de Vijver

et al . Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6.

16.

ABDA–Bundesvereinigung Deutscher Apothekerverbaende e.V. Die Apotheke–Zahlen, Daten, Fakten 2016. Berlin. 1-60 (2016). Available: https://www.abda.de/fileadmin/assets/Pressetermine/2016/TdA_2016/ABDA_ZDF_2016_Brosch.pdf (accessed June 18, 2017).

17.

Bionity.com . Freie Universität first institution in Germany to integrate medication management into the pharmacy study program. Nov. 1, 2016. Available: www.bionity.com/en/news/160321/freie-universitaet-first-institution-ingermany-to-integrate-medication-management-into-the-pharmacy-study-program.html (accessed March 3, 2017).

18.

Klein

Krämer

Otto

Impact of a pharmaceutical care program on liver transplanted patients’ compliance with immunosuppressive medication—a prospective, randomized, controlled trial using electronic monitoring. Transplantation 2009;87(6):839-47.

19.

Simons

Ringsdorf

Braun

et al . Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support Care Cancer 2011;19:1009-18.

20.

Bundesministerium für Gesundheit. Das E-Health-Gesetz. 2017. Available: https://www.bundesgesundheitsministerium.de/themen/krankenversicherung/e-health-gesetz/e-health.html (accessed June 18, 2017).

21.

Raynor

Booth

Blenkinsopp

Effects of computer generated reminder charts on patients’ compliance with drug regimens. BMJ 1993;1(306):1158-61.

22.

Botermann

Krueger

Eickhoff

et al . Patients’ handling of a standardized medication plan: a pilot study and method development. Patient Pref Adherence 2016;10:621-30.

23.

Botermann

Monzel

Krueger

et al . Evaluating patients’ comprehensibility of a standardized medication plan. Eur J Clin Pharmacol 2016;72:1229-37.

24.

Morris

Halperin

JA.

Effects of written drug information on patient knowledge and compliance: a literature review. Am J Pub Health 1979;69:47-52.

25.

Deberry

Jefferies

Light

MR.

Teaching cardiac patients to manage medications. Am J Nurs 1975;75:2191-3.

26.

Khandelwal

Duncan

Ahmed

et al . Oral chemotherapy program improves adherence and reduces medication wastage and hospital admissions. J Natl Compr Canc Netw 2012;10:618-25.

27.

Bekker

Melis

Egberts

ACG

et al . Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy. Res Social Adm Pharm 2018;pii:S1551-7411(17)30878-1.

28.

Fasola

Aita

Marini

et al . Drug waste minimisation and cost-containment in medical oncology: two-year results of a feasibility study. BMC Health Serv Res 2008;8:70.

29.

Beahm

Tsuyuki

RT.

Innovative pharmacy practice: Melanie Danilak. Can Pharm J (Ott) 2016;150:14-16.

30.

Berlin Apotheke: Onkologie. 2017. Available: http://www.berlinapotheke.de/unsere-schwerpunkte/onkologie (accessed June 18, 2017).

31.

Mazor

Clauser

Yood

Gurwitz

JH.

A demonstration of the impact of response bias on the results of patient satisfaction surveys. Health Serv Res 2002;37:1403-17.

32.

Timmreck

Randolph

JF.

Smoking cessation: clinical steps to improve compliance. Geriatrics 1993;48:63-66.

33.

Farmer

KC.

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-90.

34.

Sumartojo

When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Resp Dis 1993;147:1311-20.